Portfolio Update

THE THROGMORTON TRUST PLC All information is at 31 August 2012 and unaudited. Performance at month end is calculated on a cum income basis One Three One Three Month Months Year Years Net asset value* 3.2% 5.2% 9.8% 91.3% Net asset value 3.2% 5.2% 6.9% 78.5% Share price 4.7% 4.8% 3.4% 79.3% Numis plus AIM (ex Inv Cos) 3.4% 5.8% 6.1% 36.6% Sources: BlackRock and Datastream * Prior to dilution arising on conversion of subscription shares. At month end Net asset value capital only: 222.12p Net asset value incl. income: 223.96p Share price: 182.00p Discount to cum income NAV 18.7% Net yield: 1.7%* Total assets: £164.5m** Net market exposure as a% of net asset value: 103.8% Ordinary shares in issue: 73,130,326*** *Calculated using current year interim and prior year final dividends paid. **Includes current year revenue and excludes the gross exposure through contracts for difference. ***Excluding 7,400,000 shares held in treasury. Ten Largest Sector Weightings % of total assets Support Services 9.7 Software & Computer Services 8.7 Oil & Gas Producers 8.6 Electronic & Electrical Equipment 7.6 Media 5.7 Financial Services 5.6 Chemicals 5.4 General Retailers 5.1 Travel & Leisure 5.1 Mining 5.1 ---- Total 66.6 ==== Market Exposure (Quarterly) 30.11.11 29.02.12 31.05.12 31.08.12 Long 113.7% 119.8% 119.1% 116.1% Short 13.4% 13.0% 12.8% 12.3% Gross exposure 127.1% 132.8% 131.9% 128.4% Net exposure 100.3% 106.8% 106.3% 103.8% Ten Largest Equity Investments (in alphabetical order) Company Ashtead Aveva Bellway Booker Elementis Howden Joinery ITE Oxford Instruments Senior Victrex Commenting on the markets, Mike Prentis and Richard Plackett, representing the Investment Manager noted: During August the NAV on a cum income only basis rose by 3.2%; the benchmark rose by 3.4%. The FTSE 100 Index rose by 1.3% during the month. Long only portfolio stock selection was negative whilst sector allocation had a slightly positive impact on relative performance. The CFD portfolio performed well with good gains on the long CFDs comfortably exceeding modest losses on the short CFDs. There were no individually significant contributors to stock selection; the largest negative contributions came from Planet Payment and Futura Medical, but both were small. Planet Payment posted weaker second quarter results, mainly due to reducing margins on multi-currency payments processing with certain customers especially in Asia. Payment volumes processed continue to grow strongly and revenue growth is still expected to be good for the full year. Futura announced that the license of its CSD500 condom to Reckitt Benckiser had been terminated because the parties could not agree the basis for commercialisation. Futura intends to partner CSD500 with one or more of the world's other leading condom or healthcare companies, from which it has received considerable interest. It has already licensed other products to such companies. This will however result in a delay in getting CSD500 to market. We still see the potential for this and Futura's other products as being very significant. We added a small holding in Perform Group, which owns digital rights to more than 200 sporting leagues, tournaments and events. It provides combined video, editorial and data content to customers, particularly betting companies, around the world. Growth has been strong and the business looks well set. 14 September 2012 ENDS Latest information is available by typing www.blackrock.co.uk/thrg on the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). Neither the contents of the Manager's website nor the contents of any website accessible from hyperlinks on the Manager's website (or any other website) is incorporated into, or forms part of, this announcement.
UK 100

Latest directors dealings